Leadership & Pay ·
Eton Pharmaceuticals appointed Danka Radosavljevic as Chief Operating Officer effective July 31, 2026
ETONEton Pharmaceuticals, Inc.
Eton Pharmaceuticals appointed Danka Radosavljevic as Chief Operating Officer effective July 31, 2026. Ms. Radosavljevic previously served as Executive Vice President of Operations for over five years and has been with the company since 2017. Her compensation includes an annual base salary of $520,800 and a target discretionary incentive bonus equal to 50% of her base salary. Eton Pharmaceuticals operates in the pharmaceutical industry, specializing in the development and commercialization of generic and specialty drugs.